Accuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed Margins
|
|
- Anabel Hoover
- 6 years ago
- Views:
Transcription
1 Accuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed Margins Juan C Cendán, MD, FACS, Dominique Coco, MD, Edward M Copeland III, MD, FACS BACKGROUND: STUDY DESIGN: RESULTS: CONCLUSIONS: My colleagues and I have been using intraoperative frozen-section analysis (FSA) to evaluate lumpectomy margins in an attempt to reduce the number of additional operations that patients with ductal carcinoma in situ or stage I and II breast cancer would have to endure. We review our experience in breast-conservation therapy (BCT) at the University of Florida (Gainesville) to determine the effectiveness of this approach. Operative reports, operative logs, and pathology reports were retrospectively reviewed for patients who had BCT from January 2001 to January Ninety-seven patients (116 operations) were reviewed. Nineteen patients required an additional operation (19.6%). Forty-three patients had positive margins on paraffin-embedded histologic analysis (44.3%). Accuracy of FSA was 84% when evaluated on a per-case basis, and 96% on a per-slide basis. False negatives were identified in 22 patients, affecting the operative pathway of 19 patients (19.6%) and were identified more frequently in cases of ductal carcinoma in situ (p 0.001). There were no false positives. Additional operative time required for FSA was approximately 13 minutes per case. Eighty-four (86.6%) patients had successful BCT and 13 patients (13.4%) required mastectomy. Intraoperative analysis of margins using FSA is effective at minimizing the number of additional operations, with 19 patients benefiting from immediate intervention in this study. The authors believe that the number of second operations prevented and the high BCT rates justify performing FSA. Ductal carcinoma in situ is more difficult to identify in FSA. Preoperative discussions with the patient should reflect these findings. (J Am Coll Surg 2005;201: by the American College of Surgeons) Breast-conservation therapy (BCT) is now a standard therapeutic option for stages I and II invasive carcinoma and ductal carcinoma in situ (DCIS). Numerous followup studies after the original work of Fisher and colleagues 1 and Veronesi and colleagues 2 have correlated the recurrence of invasive carcinoma and DCIS with the presence of tumor at or near a lumpectomy margin. The standard practice of evaluating breast margins involves a histologic review of tissue embedded in paraffin and stained with hematoxylin and eosin ( permanent section ). This method provides an acceptable histologic definition of both glandular and adipose tissue. Unfortunately, time requirements for processing tissue in formalin and embedding in paraffin does not allow Competing Interests Declared: None. Received January 31, 2005; Accepted March 18, From the Department of Surgery (Cendán, Copeland) and Department of (Coco), University of Florida, College of Medicine, Gainesville, FL. Correspondence address: Juan C Cendán, MD, Department of Surgery, University of Florida, Box , JHMHC, Gainesville, FL for its use intraoperatively. This potentially limits the initial operation by requiring patients to endure an additional operation for reexcision if the margins happen to be involved. Freezing tissue in a glycol-based polyethylene-embedding compound (frozen-section analysis [FSA]) is an alternative embedding method that can be performed in a relatively short period of time and allows for its use intraoperatively. FSA has historically been accurate in identifying the pathologic etiology of palpable and nonpalpable breast masses. 3 Currently, there are fe w studies addressing the accuracy of FSA in evaluating breast margins. Adipose tissue is difficult to freeze and pathologists generally agree that frozen breast margins are difficult to interpret because of the additional challenge of identifying a smaller focus of tumor in a bed of adipose tissue. The degree of inaccuracy is largely unknown. The University of Florida in Gainesville has been evaluating breast margins with FSA over the last 10 years under the hypothesis that the accuracy of FSA is sufficient to reduce a sub by the American College of Surgeons ISSN /05/$30.00 Published by Elsevier Inc. 194 doi: /j.jamcollsurg
2 Vol. 201, No. 2, August 2005 Cendán et al Intraoperative Analysis of Lumpectomy Margins 195 Abbreviations and Acronyms BCT breast-conservation therapy DCIS ductal carcinoma in situ FSA frozen-section analysis MRM modified radical mastectomy stantial number of additional operations to justify its use. We retrospectively review our institution s records over the preceding 3 years to evaluate the efficacy of this method. METHODS Identification of patients, demographic data, and conduct of operations Patients with stage I or II invasive breast cancer or DCIS who underwent BCT at the University of Florida in Gainesville between January 1, 2001 and January 2004 were identified through an IRB-approved database search (University of Florida IRB no. 623; 2003). Only female patients were included. Age, date of the procedure, preoperative and postoperative diagnosis, tumor size and location, frozen-section diagnosis, and number of frozen sections performed were obtained by reviewing operative and pathology reports. All patients had a tissue diagnosis before their operation. The possibility of proceeding to a modified radical mastectomy was discussed with patients before their operation. Two of the authors (EMC, JC) were involved in all of the operations reviewed. A sentinel lymph node biopsy was included in every operation after the lumpectomy for those with invasive cancer and a select number of those with DCIS. All instrumentation and gloves were changed before reexcising margins, if a reexcision was performed. Between five and six margins were obtained separately from the lumpectomy cavity in an en-face fashion (lateral, medial, inferior, superior, deep, and superficial) and sent to pathology for evaluation. Margins were not obtained from the lumpectomy specimen. En-face margins were embedded in a glycol-based polyethylene-embedding compound and quickly frozen in an isopentane bath at 60 F. Frozen blocks were then sectioned using a Shandon Cryotome, stained with an hematoxylin and eosin, and then evaluated by a University of Florida pathologist assigned to interpret all frozen sections that day. Comparison of FSA and permanent sections After the evaluation and rendering of the diagnosis, the frozen tissue was fixed in formalin and routinely processed to paraffin-embedded blocks. Frozen-section diagnoses were compared with the permanent pathology slides and categorized as true positive, true negative, false positive, or false negative, accordingly. Sensitivity, specificity, positive, and negative predictive values for the FSA diagnoses were then calculated according to all the margins performed, irrespective of clinical outcomes and then with respect to clinical outcomes. For example, if a false-negative diagnosis were given to one of six margins performed in a single case, FSA would be considered inaccurate for the entire case, despite making five correct diagnoses on the other margins. Statistical evaluation Overall incidence of cancer at a margin was used to establish a baseline expected proportion. Presence of cancer at the margins for invasive ductal and lobular cancer and DCIS was compared with the null hypothesis that all tumor types would be found at a margin equally. The hypothesis was tested using a two-tailed chi-square analysis and significance was defined as p Similarly, the FSA results for each individual pathologic diagnosis were tested against the permanent pathology using a two-tailed chi-square analysis to determine if there was any marked difference between the FSA and permanent results, dependent on the pathologic subtype. Where appropriate, descriptive data are presented as mean 2 SD. Statistical analysis was performed using the SISA web-based package (Vitenbroek DG, SISA Binomial 1997, available at: index.htm, accessed on October 9, 2004). RESULTS Demographics Average patient age was 59.4 ( 11.4) years old. Average tumor size was 1.46 ( 1.4) cm. There were 57 (59%) needle-localization guided excisions and 40 (41%) open excisions. Preoperatively identified tumor characteristics are shown in Table 1. Of 97 patients reviewed, 54 (55%) had true-negative margins on FSA and permanent sections on the initial excision and required no additional operative intervention. Forty-three patients had at least one positive margin on permanent pathology (44%). Twenty-five of these 43 patients had at least one true-positive margin on
3 196 Cendán et al Intraoperative Analysis of Lumpectomy Margins J Am Coll Surg Table 1. Preoperatively Identified Tumor Types n Infiltrating ductal 57 Infiltrating lobular 7 Ductal carcinoma in situ 33 FSA, which resulted in additional intervention at the time of initial lumpectomy (25.8%). Of particular importance, 18 patients had a false-negative margin on initial excision, requiring an additional delayed operation (18.6% false negative, Fig. 1). True positives Of the 25 true-positive patients, 2 underwent immediate modified radical mastectomy (MRM) because of multiple positive margins and the remaining 23 underwent reexcision of the positive margins, in an immediate attempt at BCT. True-negative margins were achieved in 14 patients on immediate reexcision and BCT was achieved. In 5 of the patients, reexcision also yielded true-positive margins and in those patients, 2 underwent immediate MRM and 2 underwent definitive, delayed 54 TN BCT achieved 2 MRM 97 Patients 43 Tumor on permanent section on any margin. (TP) 25 TP on FSA 18 FN* SEE 2nd Tier Below 23 procedures (one skin-sparing and one MRM). In 1 patient, BCT was achieved by reresecting a true-positive margin. Four patients had false-negative margins and are repor ted here (Fig. 1). False negatives On the initial excisions, 18 patients had at least a single false-negative margin, prompting consideration for a second, separate operation. An additional 4 patients had a false-negative margin on immediate reexcision. Three patients did not pursue or require additional operations. One patient with DCIS chose not to reoperate because of advanced age and comorbidities. Two patients had a margin involved with lobular carcinoma in situ and did not warrant reexcision. The remaining 19 patients underwent additional operations; 7 had MRM, and 12 achieved BCT using FSA; of this group, 5 patients had true-positive results at the time of repeat lumpectomy, allowing additional margins to be taken until a negative result was obtained. Patient group benefited by FSA Twenty-five patients benefited from FSA with key intraoperative decisions made based on the finding of cancer at a margin. Of these, 19 patients with tumor-bearing margins did not require a second trip to the operating room because FSA allowed for either true-negative margins to be obtained (15 patients), or mastectomy be performed (4 patients), at the initial operative setting. The remaining 6 patients returned to the operating room at a separate time to allow for reconstruction (2 patients) or because of false-negative margins during the reexcision (4 patients). 14 TN BCT Achieved 5 TP (4 MRM, 1 BCT) 9 Tumor on permanent 2nd Tier of Surgery 4 FN** Histologic evaluation Six hundred twenty-eight margins were evaluated by FSA and permanent section (5.4 margins per operation). Ninety margins were tumor-bearing on permanent pa- 18 FN* + 4 FN** 19 7 MRM 12 BCT 3 dropouts Figure 1. Clinical impact of frozen-section analysis on patients. BCT, breast-conservation therapy; FN, false negatives; FSA, frozensection analysis; NRM, modified radical mastectomy; TN, true negatives; TP, true positives. *FN from first tier of operations. **FN from second tier of operations. Table 2. Number of Slides Revealing Tumor by Cell Type on Frozen-Section Analysis and Permanent FSA Permanent pathology Infiltrating ductal Infiltrating lobular DCIS Lobular carcinoma in situ 2 3 Mucinous carcinoma 2 Total 57 90
4 Vol. 201, No. 2, August 2005 Cendán et al Intraoperative Analysis of Lumpectomy Margins 197 Table 3. Number of Slides Containing Tumor by Type Total no. of slides Tumor present on FSA (n) Tumor present on permanent pathology n % Infiltrating ductal Infiltrating lobular DCIS *Chi-square analysis reflects a difference in the anticipated distribution of these cases, p 0.001, chi-square thology. Table 2 shows the distribution by carcinoma type. Fifty-seven of the 90 tumor-bearing margins (63.3%) were diagnosed correctly by FSA. When separated by carcinoma type, the distribution is shown in Table 3. Of the three main tumor types, invasive lobular cancer was most frequently tumor-bearing at the margins (18 of 45 slides, 40%); DCIS followed in frequency with 51 of 211 slides (24.2%); and invasive ductal cancer was least frequently tumor-bearing (16 of 385 slides, 4.2%). The difference between these groups was considerable (chi-square 83.7, p 0.001). Difference between FSA and permanent sections of the invasive cancers was not substantial, but DCIS was missed more often on FSA when compared with the invasive cancers on permanent sections, p ( Table 4). Accuracy of the procedure Six hundred twenty-eight pathologic slides were evaluated for the correlation between the FSA and permanent histology; accuracy was 96% (95% CI, %) with a sensitivity of 65%, a negative predictive value of 94%, and 100% specificity and positive predictive value ( Table 5). The 97 patients under went 116 separate operations, yielding 134 different sets of slides for FSA; on a per case basis accuracy was 84% (95% CI, %) with sensitivity of 59%, a negative predictive value of 78% and 100% specificity and positive predictive value. DISCUSSION Ninety margins were tumor-bearing on paraffinembedded analysis. Fifty-seven of those 90 were accurately diagnosed on FSA (63.3%). FSA accuracy in diagnosing breast margins has been largely unstudied and has not gained widespread clinical acceptance. Cox and colleagues 4 repor ted an FSA sensitivity of 77% and Table 4. Analysis of Margin Involvement Accuracy Stratified by Tumor Type Observed on FSA Expected (permanent) Chi-square, two-tailed p value Infiltrating ductal Tumor-bearing No tumor Infiltrating lobular Tumor-bearing No tumor DCIS Tumor-bearing No tumor specificity of 100% on 114 breast margins evaluated. Sauter and colleagues 5 repor ted 90% sensitivity and 97% specificity on 359 margins evaluated by FSA and Weber and colleagues 6 repor ted a sensitivity of 91% and specificity of 100% in their study. Our results more closely resemble that of Cox and colleagues 4 a n d we we re unable to achieve the high sensitivity reported by Weber, Sauter and colleagues 5,6 ; overall accuracy in this study was excellent (84% to 96%, depending whether the analysis is on, respectively, a per case or per slide basis). In our study, 24% of patients required immediate reexcision at the time of the initial lumpectomy. This is slightly less than that defined by Pinotti and Car valho 7 who reported a 40.8% immediate reexcision rate; their technique also incorporated simultaneous combination of radiologic and histopathologic evaluation and their initial margins may not have been as wide as in our patients. Our technique does attempt to obtain a 1-cm margin around the tumor, especially when the tumor is palpable. The ill-defined nature of DCIS and invasive lobular cancer are reflected in our finding a tumor at the margins in these pathologic entities more frequently. Table 5. Accuracy of the Frozen-Section Analysis Method Described on a Per-Case and Per-Slide Basis Initial operation Overall based on case Overall based on slides N Sensitivity Specificity PPV NPV Accuracy (%), 95% CI 82, , , NPV, negative predictive value; PPV, positive predictive value.
5 198 Cendán et al Intraoperative Analysis of Lumpectomy Margins J Am Coll Surg Obtaining 100% specificity supports the belief that FSA is a safe method for interpreting margins by avoiding potential situations where additional breast tissue is removed unnecessarily. For this reason, our institution has been reluctant to try touch preparation cytology, given a number of studies that have had false-positive diagnoses. Another strength of this study was use of multiple general pathologists. We believe that this reflects a more common support environment for a practicing surgeon and will make the data more relevant outside of specialized breast care centers. From a clinical perspective, 22 of the 43 patients with positive margins (51.2%) had at lease one false-negative margin, either at the first excision or at reexcision. Two patients chose not to return to the operating room and 1 had lobular carcinoma in situ involving a margin. Nineteen patients had a second operation. Although an argument questioning use of FSA could arise from the fact that 51.2% of the patients with positive margins were incorrectly diagnosed; in our view, the more important fact is that critical intraoperative decisions were made based on the FSA in 25 patients, and 19 patients did not require a second operation all of whom would have required another operation without FSA. When FSA of margins is used, the patient must understand that the pathologic status of her margins will not be known until the permanent sections are available. On the other hand, this is true for all patients in whom FSA margins are not used. Those patients with DCIS and lobular invasive cancer are at the highest risk for needing an additional procedure because of a false-negative FSA. Likewise, the technique can be valuable when attempting BCT on large lesions in relation to breast size. If negative FSA can be obtained with a large lesion and the cosmetic result is acceptable, then BCT is achieved. If margins are positive or cosmetic result is poor, then the patient should be prepared for mastectomy. Many patients will take comfort in knowing that an attempt at BCT was tried and then will be more accepting of a mastectomy. A breast cancer that is so large as to preclude BCT and require mastectomy will, in our treatment algorithm, require radiation therapy, and precludes use of immediate reconstruction. FSA required 13 minutes, the time required to close the wound. If immediate reexploration was required because of a positive margin, the wound was reopened to do so. Important information was available intraoperatively in 25 of 43 patients; and, at a minimum, a second operation was avoided in 19 of 43 patients with tumor at the margins (44.2%), with no practical increase in operative time for those patients with negative margins on FSA. REFERENCES 1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus radiation for the management of invasive breast cancer. N Engl J Med 2002;347: Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: Ferreiro JA, Gisvold JJ, Bostwick DG. Accuracy of frozen-section diagnosis of mammographically directed breast biopsies: results of 1,490 consecutive cases. Am J Surg Pathol 1995;19: Cox C, Ku NN, Reintgen DS, et al. Touch prep cytology of breast lumpectomy margins with histologic correlation. Arch Surg 1991;126: Sauter ER, Hoffman JP, Ottery FD, et al. Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisions. Cancer 1994;73: Weber S, Storm FK, Stitt J, Mahvi DM. The role of frozen section analysis of margins during breast conservation surgery. Cancer J Sci Am 1997;3: Pinotti JA, Carvalho FM. Intraoperative pathological monitorization of surgical margins: a method to reduce recurrences after conservative treatment for breast cancer. Eur J Gynaecol Oncol 2002;23:11 16.
Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery
Last Review Status/Date: December 2014 Page: 1 of 6 Intraoperative Assessment of Surgical Description Breast-conserving surgery as part of the treatment of localized breast cancer is optimally achieved
More informationHandheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery
Last Review Status/Date: December 2016 Page: 1 of 6 Intraoperative Assessment of Surgical Description Breast-conserving surgery as part of the treatment of localized breast cancer is optimally achieved
More informationLocal recurrence in lumpectomy patients after imprint cytology margin evaluation
The American Journal of Surgery 188 (2004) 349 354 Scientific paper Local recurrence in lumpectomy patients after imprint cytology margin evaluation Elizabeth Weinberg, M.D., Charles Cox, M.D.,* Elisabeth
More informationHandheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery
7.01.140 Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery Section 7.0 Surgery Subsection Description Effective Date November 26, 2014
More informationRecurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction
Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing
More informationSurgical Therapy: Sentinel Node Biopsy and Breast Conservation
Surgical Therapy: Sentinel Node Biopsy and Breast Conservation Stephen B. Edge, MD Professor of Surgery and Oncology Roswell Park Cancer Institute University at Buffalo Dr. Roswell Park: Tradition in Cancer
More informationOptical Intra-operative Assessment of Breast Tumor Margins
Optical Intra-operative Assessment of Breast Tumor Margins Stephanie Kennedy and Torre Bydlon Department of Biomedical Engineering Fitzpatrick Institute of Photonics Duke University 2 Ann Surg Onc 15:1271-1272,
More informationImage guided core biopsies:
Recommendations on the Surgical, Radiologic and Pathologic Approaches to Breast Disease: Using best practices based on multidisciplinary methodologies developed through the Allina Breast Committee. Image
More informationBilateral Reduction Mammaplasty as an Oncoplastic Technique for the Management of Early-Stage Breast Cancer in Women with Macromastia
Bilateral Reduction Mammaplasty as an Oncoplastic Technique for the Management of Early-Stage Breast Cancer in Women with Macromastia Russell E. Ettinger, MD, a Shailesh Agarwal, MD, a Paul H. Izenberg,
More informationSurgeons Experience In Breast Conserving Surgery: Does It Influence Surgical Margin?
Original Research Article Surgeons Experience In Breast Conserving Surgery: Does It Influence Surgical Margin? Shahrun Niza AS 1 ( ), Ussof Eskaandar MH 2, Nani Harlina ML 1, Razrim R 1, Rohaizak M 1 1
More informationUse of a Protease Activated System for Real-time Breast Cancer Lumpectomy Margin Assessment
Use of a Protease Activated System for Real-time Breast Cancer Lumpectomy Margin Assessment Barbara L. Smith, MD, PhD Professor of Surgery, Harvard Medical School Division of Surgical Oncology Massachusetts
More informationTable of contents. Page 2 of 40
Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the
More informationAdvances in Localized Breast Cancer
Advances in Localized Breast Cancer Melissa Camp, MD, MPH and Fariba Asrari, MD June 18, 2018 Moderated by Elissa Bantug 1 Advances in Surgery for Breast Cancer Melissa Camp, MD June 18, 2018 2 Historical
More informationSSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer
SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer Dr. Yvonne Tsang St. Paul s Hospital Introductions Breast-conserving
More informationConcordance with Breast Cancer Pathology Reporting Practice Guidelines
Concordance with Breast Cancer Pathology Reporting Practice Guidelines Neal W Wilkinson, MD, FACS, Azin Shahryarinejad, MD, Janet S Winston, MD, Nancy Watroba, MPA, Stephen B Edge, MD, FACS BACKGROUND:
More informationRESEARCH REVIEW Diagnostic Performance of a Novel Device for Real-Time Margin Assessment in Lumpectomy Specimens
Journal of Surgical Research 160, 277 281 (2010) doi:10.1016/j.jss.2009.02.025 RESEARCH REVIEW Diagnostic Performance of a Novel Device for Real-Time Margin Assessment in Lumpectomy Specimens Itzhak Pappo,
More informationFactors associated with the misdiagnosis of sentinel lymph nodes using touch imprint cytology for early stage breast cancer
ONCOLOGY LETTERS 2: 277-281, 2011 Factors associated with the misdiagnosis of sentinel lymph nodes using touch imprint cytology for early stage breast cancer Yi-zuo Chen 1,4*, Jia-Xin Zhang 1*, Jia-Jian
More informationBreast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
More informationPosition Statement on Management of the Axilla in Patients with Invasive Breast Cancer
- Official Statement - Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) for the
More informationFine-Needle Aspiration and Cytologic Findings of Surgical Scar Lesions in Women With Breast Cancer
148 Fine-Needle Aspiration and Cytologic Findings of Surgical Scar Lesions in Women With Breast Cancer Ehud Malberger, DMD, FIAC,* Yeouda Edoute, MD, PhD,t Osnaf Toledano, MD,* and Dov Sapir, MDS Benign
More informationCorrelation of Imprint Cytology of Axillary Lymph Nodes in Breast Carcinoma with the Histopathological Diagnosis
Occupational Correlation Health of Hazards Imprint Correlation of Imprint Cytology of Axillary Lymph Nodes in Breast Carcinoma with the Histopathological Diagnosis Ranabhat SK a, Karki A b, Shah GJ c and
More informationOncoplastic breast surgery in a Danish perspective II: Reconstructive strategy in oncoplastic breast surgery
Oncoplastic breast surgery in a Danish perspective II: Reconstructive strategy in oncoplastic breast surgery Michael Rose, MD Department of Surgery and Plastic Surgery, Hospital of Southwest Jutland, Denmark
More informationResection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland
Resection Margins in Breast Conserving Surgery Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Breast Conserving Surgery 1 Probably one of the most important innovation in cancer surgery
More informationRadioactive Seed Localization of Nonpalpable Breast Lesions
Subject: Radioactive Seed Localization of Page: 1 of 7 Last Review Status/Date: March 2017 Radioactive Seed Localization of Description Radioactive seed localization is used to detect nonpalpable breast
More informationThe Value of Intraoperative Examination of Axillary Sentinel Nodes in Carcinoma of the Breast.
Thomas Jefferson University Jefferson Digital Commons Department of Pathology, Anatomy, and Cell Biology Faculty Papers Department of Pathology, Anatomy, and Cell Biology 11-1-2008 The Value of Intraoperative
More informationAdvances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015
Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationBreast Surgery: Yesterday, Today and Tomorrow
Breast Surgery: Yesterday, Today and Tomorrow Baptist Hospital Gladys L. Giron, MD, FACS October 11,2014 Homestead Hospital Baptist Children s Hospital Doctors Hospital Baptist Cardiac & Vascular Institute
More informationFor additional information on meeting the criteria for Mohs, see Appendix 2.
Position Statement on Appropriate Uses of Paraffin Sections in Association (Approved by the Board of Directors: August 1, 2011; Revised November 5, 2011; Revised August 9, 2014) According to AMA/CPT, Mohs
More informationBreast Reconstruction Postmastectomy. Using DermaMatrix Acellular Dermis in breast reconstruction with tissue expander.
Breast Reconstruction Postmastectomy. Using DermaMatrix Acellular Dermis in breast reconstruction with tissue expander. Strong and flexible Bacterially inactivated Provides implant support Breast Reconstruction
More informationIs Intraoperative Frozen Section Analysis of Reexcision Specimens of Value in Preventing Reoperation in Breast-Conserving Therapy?
AJCP / Original Article Is Intraoperative Frozen Section Analysis of Reexcision Specimens of Value in Preventing Reoperation in Breast-Conserving Therapy? Julie M. Jorns, MD, 1 Stephanie Daignault, MS,
More informationAn evaluation of intraoperative digital specimen mammography versus conventional specimen radiography for the excision of nonpalpable breast lesions
The American Journal of Surgery (2013) 205, 703-710 Clinical Surgery An evaluation of intraoperative digital specimen mammography versus conventional specimen radiography for the excision of nonpalpable
More informationBreastScreen Aotearoa Annual Report 2015
BreastScreen Aotearoa Annual Report 2015 EARLY AND LOCALLY ADVANCED BREAST CANCER PATIENTS DIAGNOSED IN NEW ZEALAND IN 2015 Prepared for Ministry of Health, New Zealand Version 1.0 Date November 2017 Prepared
More informationBREAST CANCER SURGERY. Dr. John H. Donohue
Dr. John H. Donohue HISTORY References to breast surgery in ancient Egypt (ca 3000 BCE) Mastectomy described in numerous medieval texts Petit formulated organized approach in 18 th Century Improvements
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationPrediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography
Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography Eyad Fawzi AlSaeed 1 and Mutahir A. Tunio 2* 1 Consultant Radiation Oncology, Chairman
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationDiagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Pathology Pathology Versions 2004 2017: Blohmer / Costa / Fehm / Friedrichs / Huober / Kreipe / Lück / Schneeweis / Sinn /
More informationARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW
doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter
More informationAngela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008
Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000
More informationAt many centers in the United States and worldwide,
ORIGINAL ARTICLES A Declining Rate of Completion Axillary Dissection in Sentinel Lymph Node-positive Breast Cancer Patients Is Associated With the Use of a Multivariate Nomogram Julia Park, MS, Jane V.
More informationClinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience
Original Article Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience Rachel Murray 1, Fantine Giap 2, Ray Lin
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationClinical Study Higher Volume at Time of Breast Conserving Surgery Reduces Re-Excision in DCIS
International Journal of Surgical Oncology Volume 2011, Article ID 785803, 10 pages doi:10.1155/2011/785803 Clinical Study Higher Volume at Time of Breast Conserving Surgery Reduces Re-Excision in DCIS
More informationGuideline for the Management of Patients Suitable for Immediate Breast Reconstruction
Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationHandout for Dr Allison s Lectures on Grossing Breast Specimens:
Handout for Dr Allison s Lectures on Grossing Breast Specimens: Dr. Kimberly H. Allison Director of Breast Pathology and Breast Pathology Fellowship Director of Residency Training in Pathology Stanford
More informationContralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks
Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks Grant W. Carlson Wadley R. Glenn Professor of Surgery Divisions of Plastic Surgery & Surgical Oncology Emory
More informationDuctal Carcinoma-in-Situ: New Concepts and Controversies
Ductal Carcinoma-in-Situ: New Concepts and Controversies James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation
More informationChanges in Surgical Management Resulting From Case Review at a Breast Cancer Multidisciplinary Tumor Board
2346 Changes in Surgical Management Resulting From Case Review at a Breast Cancer Multidisciplinary Tumor Board Erika A. Newman, MD 1 Amy B. Guest, MD 2 Mark A. Helvie, MD 2 Marilyn A Roubidoux, MD 2 Alfred
More informationCase Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
More informationInitial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens
Initial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens Silvia Skripenova, MD; Lester J. Layfield, MD N Context. Margin status
More informationPROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT
PROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT Author: Dr Sally Ann Hales On behalf of the Breast and pathology CNGs Written: March 2005 Reviewed by CNG: June 2009 &
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationPaget's Disease of the Breast: Clinical Analysis of 45 Patients
236 Paget's Disease of the Breast: Clinical Analysis of 45 Patients Mingfian Yang Hao Long Jiehua He Xi Wang Zeming Xie Department of Thoracic Oncology, Cancer Center of Sun Yat-sen University, Guangzhou
More informationPreoperative Needle Biopsy Improves the Quality of Breast Cancer Surgery
Preoperative Needle Biopsy Improves the Quality of Breast Cancer Surgery Ted A James, MD, FACS, John L Mace, PhD, Beth A Virnig, PhD, Berta M Geller, EdD BACKGROUND: STUDY DESIGN: RESULTS: CONCLUSIONS:
More informationThe Case FOR Oncoplastic Surgery in Small Breasts. Barbara L. Smith, MD, PhD Massachusetts General Hospital Harvard Medical School Boston, MA USA
The Case FOR Oncoplastic Surgery in Small Breasts Barbara L. Smith, MD, PhD Massachusetts General Hospital Harvard Medical School Boston, MA USA Changing issues in breast cancer management Early detection
More informationPage 1. AHN-JHU Breast Cancer Symposium. Novel Local Regional Clinical Trials. Background. Neoadjuvant Chemotherapy Benefit.
AHN-JHU Breast Cancer Symposium Novel Local Regional Clinical Trials March 22, 2019 Thomas B. Julian, MD, FACS Associate Medical Director, Cancer Program Development, ANH Cancer Institute Background In
More informationDuctal Carcinoma in Situ (DCIS)
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Ductal Carcinoma in Situ (DCIS) Ductal Carcinoma in Situ DCIS Versions 2002 2017: Audretsch / Blohmer / Brunnert / Budach /
More informationBreast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options
A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate
More informationUse of the dye guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
456 Use of the dye guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection TOMOKO TAKAMARU 1, GORO KUTOMI 1, FUKINO SATOMI 1, HIROAKI
More informationACRIN 6666 Therapeutic Surgery Form
S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).
More informationStudy of Fine Needle Aspiration Cytology of Breast Lump: Correlation of Cytologically Malignant Cases with Their Histological Findings
Study of Fine Needle Aspiration Cytology of Breast Lump: Correlation of Cytologically Malignant Cases with Their Histological Findings Touhid Uddin Rupom 1, Tamanna Choudhury 2, Sultana Gulshana Banu 3
More informationFeasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study
[ABS-0078] GBCC 2018 Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study Eun Young Kim 1, Kwan Ho Lee 1, Yong
More informationBREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School
BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration
More informationRepeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates
Ann Surg Oncol (2012) 19:3771 3776 DOI 10.1245/s10434-012-2404-5 ORIGINAL ARTICLE BREAST ONCOLOGY Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the
More informationExtent of Lumpectomy for Breast Cancer After Diagnosis by Stereotactic Core Versus Wire Localization Biopsy
Annals of Surgical Oncology, 6(4):330 335 Published by Lippincott Williams & Wilkins 1999 The Society of Surgical Oncology, Inc. Extent of Lumpectomy for Breast Cancer After Diagnosis by Stereotactic Core
More informationHOSPITAL MODELO - LA CORUÑA, Spain
- LA CORUÑA, Spain General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 8 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationInvasive Papillary Breast Carcinoma
410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationCellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?
natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,
More informationBreast Specimen Processing and Reporting With an Emphasis on Margin Evaluation. A College of American Pathologists Survey of 866 Laboratories
Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation A College of American Pathologists Survey of 866 Laboratories Anthony J. Guidi, MD; Joseph A. Tworek, MD; Daniel D. Mais,
More informationBreast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
More informationSupplementary Online Content
Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.
More informationInvasive Breast Cancer: Mastectomy vs. Lumpectomy- A Difficult Decision
ISPUB.COM The Internet Journal of Radiology Volume 11 Number 1 Invasive Breast Cancer: Mastectomy vs. Lumpectomy- A Difficult Decision C Hall, S Keene Citation C Hall, S Keene. Invasive Breast Cancer:
More informationRUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES
RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES At the completion of Breast Fellowship training, the
More informationApplicability of the ACOSOG Z0011 Criteria in Women with High-Risk Node-Positive Breast Cancer Undergoing Breast Conserving Surgery
Ann Surg Oncol (2015) 22:1128 1132 DOI 10.1245/s10434-014-4090-y ORIGINAL ARTICLE BREAST ONCOLOGY Applicability of the ACOSOG Z0011 Criteria in Women with High-Risk Node-Positive Breast Cancer Undergoing
More informationOriginal Article. Spontaneous Healing of Breast Cancer
Breast Cancer Vol. 12 No. 2 April 2005 Original Article Rie Horii 1, 3, Futoshi Akiyama 1, Fujio Kasumi 2, Morio Koike 3, and Goi Sakamoto 1 1 Department of Breast Pathology, the Cancer Institute of the
More informationSang Min Hong*, Eun Young Kim*, Kwan Ho Lee, Yong Lai Park, Chan Heun Park
ORIGINAL ARTICLE J Breast Dis 2018 June; 6(1): 11-19 JBD Journal of Breast Disease Predictors of Positive or Close Surgical Margins in Breast-Conserving Surgery for Patients with Breast Cancer Sang Min
More informationRadioactive Seed Localization of Nonpalpable Breast Lesions
Radioactive Seed Localization of Nonpalpable Breast Lesions Policy Number: 6.01.57 Last Review: 11/2017 Origination: 11/2016 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue
More informationSurgery for Breast Cancer
Surgery for Breast Cancer 1750 Mastectomy - Petit 1894 Radical mastectomy Halsted Extended, Super radical mastectomy 1948 Modified radical mastectomy Patey 1950-60 WLE & RT Baclesse, Mustakallio 1981-85
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationThe role of the cytologist in breast cancer screening
The role of the cytologist in breast cancer screening I.Seili-Bekafigo, MD, PhD Clinical cytologist KBC Rijeka Croatian Society for Clinical Cytology Fine needle aspiration (FNA, FNAB, FNAC) Fine needle
More informationPathology Report Patient Companion Guide
Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit
More informationANATOMICAL PATHOLOGY TARIFF
ANATOMICAL PATHOLOGY TARIFF A GUIDE TO UTILISATION. The following guidelines have been agreed by consensus of Anatomical Pathologists who are members of the Anatomical Pathologist s Group, or the National
More informationVolume 2 Issue ISSN
Volume 2 Issue 3 2012 ISSN 2250-0359 Correlation of fine needle aspiration and final histopathology in thyroid disease: a series of 702 patients managed in an endocrine surgical unit *Chandrasekaran Maharajan
More informationObjectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014
Intraoperative Consultation of the Whipple Resection Specimen Pathology Update Faculty of Medicine, University of Toronto November 15, 2014 John W. Wong, MD, FRCPC Department of Anatomical Pathology Sunnybrook
More informationSo, we already talked about that recognition is the key to optimal treatment and outcome.
Hi, I m Dr. Anthony Lucci from the University of Texas MD Anderson Cancer Center in Houston. And today, I d like to talk to you about the role of surgery in inflammatory breast cancer patients. So, there
More informationMitchell Buller, MEng, a Adee Heiman, BA, a Jared Davis, MD, b ThomasJ.Lee,MD, b Nicolás Ajkay, MD, FACS, c and Bradon J. Wilhelmi, MD, FACS b
Immediate Breast Reconstruction of a Nipple Areolar Lumpectomy Defect With the L-Flap Skin Paddle Breast Reduction Design and Contralateral Reduction Mammoplasty Symmetry Procedure: Optimizing the Oncoplastic
More informationA712(18)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More informationImplications of ACOSOG Z11 for Clinical Practice: Surgical Perspective
:$;7)#*8'-87*4BCD'E7)F'31$4.$&'G$H'E7)F&'GE'>??ID >?,"'@4,$)4*,#74*8'!74/)$++'74',"$'A.,.)$'7%'()$*+,'!*42$)!7)74*67&'!3 6 August 2011 Implications of ACOSOG Z11 for Clinical
More informationSummary CHAPTER 1. Introduction
Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which
More informationConsensus Guideline on Accelerated Partial Breast Irradiation
Consensus Guideline on Accelerated Partial Breast Irradiation Purpose: To outline the use of accelerated partial breast irradiation (APBI) for the treatment of breast cancer. Associated ASBS Guidelines
More informationAtypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy
Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Breast Cancer is the most common cancer diagnosed in women in the United
More informationMammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand
Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer
More informationReview of Literatures
Review of Literatures Fine needle biopsy was popular in the Scandinavian countries some four decades ago. Though FNAC for any palpable tumor was first introduced in America in the 1920s by Martin, Ellis
More informationEducational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery
Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery Goal The goal of the Breast Surgery rotation is to develop the knowledge, skills and attitudes necessary to evaluate,
More informationHow to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer
Global Breast Cancer Conference 2016 & 5 th International Breast Cancer Symposium April 29 th 2016, 09:40-10:50 How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer
More informationAnatomic Pathology / FSM in BCT Significantly Reduces Reoperative Rates
Anatomic Pathology / FSM in BCT Significantly Reduces Reoperative Rates Intraoperative Frozen Section Analysis of Margins in Breast Conserving Surgery Significantly Decreases Reoperative Rates One-Year
More information